English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 45422/58598 (78%)
造訪人次 : 2541314      線上人數 : 186
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: http://libir.tmu.edu.tw/handle/987654321/5820


    題名: 牛樟芝萃取物抑制微小膠質細胞發炎機制之探討
    Study on the anti-inflammatory mechanisms of Taiwanofungus in microglia
    作者: 黃君婷
    Chun-Ting Huang
    貢獻者: 醫學研究所
    關鍵詞: 樟芝
    微小膠質細胞
    發炎反應
    Taiwanofungus camphoratus
    microglia
    inflammation
    日期: 2006
    上傳時間: 2009-09-11 15:43:55 (UTC+8)
    摘要: 樟芝 (Taiwanofungus,學名Taiwanofungus camphoratus)為台灣特有的真菌類,具有抗發炎、抗氧化、血管舒張以及抗B型肝炎病毒等生理活性,然而,其詳細抗發炎成分與機制尚未明確。在本研究論文中,我們使用野生型樟芝、液態培養樟芝和固態培養樟芝的冷水、甲醇和熱水三種萃取物,並檢驗它們在微小膠質細胞中的抗發炎作用,並進而探討樟芝萃取物對於預防腦部退化性疾病的產生可能扮演的角色。微小膠質細胞為腦中的免疫細胞,扮演著監控與防禦的角色。然而活化的微小膠質細胞會大量表現誘生型一氧化氮合成? (inducible nitric oxide synthase, iNOS)並使iNOS的代謝物一氧化氮 (NO) 大量產生,iNOS和NO的生合成對於發炎反應和腦部退化性疾病的形成扮演重要的角色。首先,以不同濃度及種類的樟芝萃取物處理EOC13.31微小膠質細胞,再以脂多醣 (LPS)和干擾素- (IFN-)誘導EOC13.31微小膠質細胞發炎,並偵測iNOS的表現。西方點墨法及反轉錄-聚合?連鎖反應顯示,在EOC13.31微小膠質細胞內,野生型樟芝、液態培養樟芝和固態培養樟芝的冷水、甲醇和熱水萃取物皆可抑制LPS和IFN- 所誘導的iNOS蛋白質和mRNA表現;然而,在我們所測試的九種樟芝萃取物中,野生型樟芝甲醇萃取物抑制效果最明顯,且隨著濃度增加其抑制iNOS和TNF-表現的效果越顯著。另外,我們進一步證實由野生型樟芝甲醇萃取物中分離出的CKJ-35-2抑制LPS和IFN- 所誘導的iNOS蛋白質表現的效果最顯著。為了確認其中的抑制機轉,西方點墨法之結果顯示野生型樟芝甲醇萃取物可抑制EOC13.31微小膠質細胞內LPS和IFN- 所誘導p-STAT1 (signal transducer and activator of transcription-1)、p-ERK (extracellular signal- regulated protein kinases)、p-JNK (c-Jun NH2-terminal protein kinases)的活性,除此之外野生型樟芝甲醇萃取物也可抑制 IB(inhibitor B)的降解和p-IB的活性。當我們改以-Amyloid (25 M)刺激細胞發炎時,野生型樟芝甲醇萃取物同樣隨濃度增加而抑制iNOS表現的效果越顯著。綜合以上結果,證實樟芝甲醇萃取物為一種抗發炎物質,可有效抑制腦部微小膠質細胞中iNOS和TNF-的表現,進而抑制微小膠質細胞發炎的情形。此篇研究報告結果顯示樟芝萃取物調節iNOS的特性也許在預防腦部細胞的發炎反應及腦部退化性疾病的形成扮演重要的角色。
    Taiwanofungus (Taiwanofungus camphoratus), a medicinal mushroom in Taiwan, is reported to provide several therapeutic benefits including anti-inflammation, antioxidation, vasorelaxation, antihepatitis B surface antigen activities, but the underlying molecular mechanisms are not well understood. In this study, we used three cultured types of wild type, Liquid-state culture, and solid-state culture Taiwanofungus extracts, and to examine their anti-inflammatory effect in microglia cells and the possible role in the protection of neurodegenerative diseases. Since microglia is the immune cell in the brain, it plays a defense and monitoring role. However, activated microglia expresses high level of inducible nitric oxide synthase (iNOS) and its metabolite nitric oxide (NO) that significantly contributes to the pathogenesis of neurodegenerative diseases. First, EOC13.31 microglia was treated with various kinds of Taiwanofungus extracts and lipopolysaccharide (LPS) and interferon- (IFN-), then detected the iNOS expression. Western blot and RT-PCR analysis demonstrated that cold water, methanol, and hot water extracts of wild type, Liquid-state culture, and solid-state culture Taiwanofungus significantly blocked the protein and mRNA expression of iNOS in LPS and IFN- -activated microglia. Among nine extracts of Taiwanofungus, methanol extracts of wild type Taiwanofungus was the most potent inhibitor on the iNOS and TNF- expression, and the inhibition by a dose-dependant manner. The CKJ-35-2 fraction of methanol extracts of wild type Taiwanofungus, effectively inhibited the iNOS expression. To clarify the mechanisms involved, methanol extracts of wild type Taiwanofungus was found to inhibit the LPS and IFN--induced the phosphorylation of extracellular signal-regulated protein kinases (ERK), c-Jun NH2-terminal protein kinases (JNK) and signal transducer and activator of transcription-1 (STAT1). Moreover, methanol extracts of wild type Taiwanofungus also inhibited NF-B activition through the prevention of inhibitor B (IB) degradation and phosphorylation. These results suggests that modulation of iNOS expression by Taiwanofungus extracts may be important in the prevention of inflammation and neurodegenerative diseases.
    資料類型: thesis
    顯示於類別:[醫學科學研究所] 博碩士論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    摘要.doc35KbMicrosoft Word137檢視/開啟
    摘要.pdf115KbAdobe PDF278檢視/開啟
    摘要.ppt131KbMicrosoft Powerpoint184檢視/開啟
    摘要.ps425KbPostscript82檢視/開啟


    在TMUIR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    著作權聲明 Copyright Notice
    • 本平台之數位內容為臺北醫學大學所收錄之機構典藏,包含體系內各式學術著作及學術產出。秉持開放取用的精神,提供使用者進行資料檢索、下載與取用,惟仍請適度、合理地於合法範圍內使用本平台之內容,以尊重著作權人之權益。商業上之利用,請先取得著作權人之授權。

      The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.

    • 瀏覽或使用本平台,視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例,並不得為任何不法目的使用TMUIR。

      By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.

    • 本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者,煩請權利人通知本平台維護人員([email protected]),將立即採取移除該數位著作等補救措施。

      TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

    Back to Top
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋